Evaluation of inhaled beta-2 agonist in management of transient tachypnea of the newborn

Evaluation of inhaled beta-2 agonist in management of transient tachypnea of the newborn

Abstract Background Transient tachypnea of the newborn (TTN) is a common cause of early neonatal respiratory distress. It is due to delayed clearance of fetal lung fluid. Aim To evaluate the effect of inhaled salbutamol, a beta-2 adrenergic agonist (β2AA), in management of TTN and to detect any side...

Full description

Bibliographic Details
Main Authors: Ahmed A. Talaat, Maha M. A. Abohashish, Tarek M. Farid, Mohab M. Salah
Format: Article
Language:English
Published: SpringerOpen 2020-01-01
Series:Bulletin of the National Research Centre
Subjects:
Newborn
Transient tachypnea
β2-agonist
Salbutamol
Online Access:https://doi.org/10.1186/s42269-020-0271-y

Internet

https://doi.org/10.1186/s42269-020-0271-y

Similar Items